<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Neuroprotection &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/neuroprotection/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 13 Jan 2026 15:49:44 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Neuroprotection &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Bis(7)-Tacrine Safeguards Retinal Ganglion Cells from Damage</title>
		<link>https://bioengineer.org/bis7-tacrine-safeguards-retinal-ganglion-cells-from-damage/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 13 Jan 2026 15:49:37 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Bis(7)-tacrine]]></category>
		<category><![CDATA[Glutamate excitotoxicity]]></category>
		<category><![CDATA[Neuroprotection]]></category>
		<category><![CDATA[Retinal ganglion cells]]></category>
		<category><![CDATA[Retinal neurodegeneration]]></category>
		<guid isPermaLink="false">https://bioengineer.org/bis7-tacrine-safeguards-retinal-ganglion-cells-from-damage/</guid>

					<description><![CDATA[The field of neuroscience is continually evolving, presenting new insights and directions that can significantly impact our understanding of neuroprotection. One recent study stands out for its intriguing focus on the protective properties of a compound known as bis(7)-tacrine. As researchers dive deeper into this area, the intricacies of how bis(7)-tacrine operates against glutamate-induced retinal [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316549</post-id>	</item>
		<item>
		<title>TFAM Reduces Mitochondrial Damage in Stroke Recovery</title>
		<link>https://bioengineer.org/tfam-reduces-mitochondrial-damage-in-stroke-recovery/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 08 Jan 2026 07:01:44 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[cerebral ischemia-reperfusion injury]]></category>
		<category><![CDATA[ischemic stroke]]></category>
		<category><![CDATA[İşte içerik için uygun 5 etiket (virgülle ayrılmış): **TFAM]]></category>
		<category><![CDATA[Mitochondrial dysfunction]]></category>
		<category><![CDATA[mitochondrial protection]]></category>
		<category><![CDATA[Neuroprotection]]></category>
		<category><![CDATA[neuroprotective therapy** **Açıklama:** 1. **TFAM:** Çalışmanın ana odağı olan molekül. 2. **Mitochondrial protection:** TFAM'in temel işlevi ve çalışmanın ana bulg]]></category>
		<category><![CDATA[reperfusion injury]]></category>
		<category><![CDATA[stroke recovery]]></category>
		<category><![CDATA[TFAM]]></category>
		<guid isPermaLink="false">https://bioengineer.org/tfam-reduces-mitochondrial-damage-in-stroke-recovery/</guid>

					<description><![CDATA[In a groundbreaking study published in Cell Death Discovery, researchers Wang, Shi, Qiu, and their team have unveiled pivotal insights into the molecular mechanisms that protect brain cells from the devastating effects of cerebral ischemia-reperfusion injury. Their work centers on the mitochondrial transcription factor A (TFAM), a signaling molecule that appears to play a crucial [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">314791</post-id>	</item>
		<item>
		<title>Neonatal Neurocritical Care for Prenatal Neurological Disorders</title>
		<link>https://bioengineer.org/neonatal-neurocritical-care-for-prenatal-neurological-disorders/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 07 Jan 2026 13:48:21 +0000</pubDate>
				<category><![CDATA[Technology]]></category>
		<category><![CDATA[İçeriğin ana temalarına göre en uygun 5 etiket: **Neonatal Neurocritical Care]]></category>
		<category><![CDATA[multidisciplinary care]]></category>
		<category><![CDATA[Neonatal Outcomes** * **Neonatal Neurocritical Care:** Makalenin ana odak noktası ve başlıkta geçen temel kavram. * **Prenatal Neurological Disorders:** Araştırmanın hedefled]]></category>
		<category><![CDATA[Neuroprotection]]></category>
		<category><![CDATA[Prenatal Neurological Disorders]]></category>
		<guid isPermaLink="false">https://bioengineer.org/neonatal-neurocritical-care-for-prenatal-neurological-disorders/</guid>

					<description><![CDATA[In a groundbreaking new study published on January 7, 2026, researchers have detailed advanced approaches in neonatal neurocritical care tailored specifically for infants diagnosed with neurological disorders before birth. This pioneering work provides a comprehensive framework aimed at optimizing outcomes for this vulnerable population by integrating prenatal diagnostics with cutting-edge neonatal interventions. The implications of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">314458</post-id>	</item>
		<item>
		<title>GLP-1 Agonist Trial in Large Vessel Occlusion</title>
		<link>https://bioengineer.org/glp-1-agonist-trial-in-large-vessel-occlusion/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 14 Dec 2025 06:39:22 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[and key findings: **GLP-1 agonists]]></category>
		<category><![CDATA[Based on the article content]]></category>
		<category><![CDATA[focusing on the core themes]]></category>
		<category><![CDATA[here are 5 appropriate tags]]></category>
		<category><![CDATA[Large Vessel Occlusion Stroke]]></category>
		<category><![CDATA[Neuroprotection]]></category>
		<category><![CDATA[novelty]]></category>
		<category><![CDATA[Reperfusion Therapy Adjunct]]></category>
		<guid isPermaLink="false">https://bioengineer.org/glp-1-agonist-trial-in-large-vessel-occlusion/</guid>

					<description><![CDATA[In a groundbreaking advancement at the intersection of endocrinology and neurology, a recent phase 2 randomized trial has unveiled promising therapeutic potential for glucagon-like peptide-1 receptor (GLP-1R) agonists in the treatment of large vessel occlusion (LVO) stroke patients undergoing reperfusion therapy. This pioneering study, published in 2025 in Nature Communications, spearheaded by Wang, Ko, Leung, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">307606</post-id>	</item>
		<item>
		<title>ARB Candesartan Shows Neuroprotection in Parkinson’s Disease</title>
		<link>https://bioengineer.org/arb-candesartan-shows-neuroprotection-in-parkinsons-disease/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 10 Dec 2025 13:18:10 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Candesartan]]></category>
		<category><![CDATA[Candesartan neuroprotection]]></category>
		<category><![CDATA[extracellular vesicles]]></category>
		<category><![CDATA[Extracellular vesicles proteomics]]></category>
		<category><![CDATA[neuroinflammation modulation]]></category>
		<category><![CDATA[Neuroprotection]]></category>
		<category><![CDATA[Neuroprotective Mechanisms]]></category>
		<category><![CDATA[Parkinson’s disease]]></category>
		<category><![CDATA[Parkinson’s disease therapy]]></category>
		<guid isPermaLink="false">https://bioengineer.org/arb-candesartan-shows-neuroprotection-in-parkinsons-disease/</guid>

					<description><![CDATA[In a groundbreaking study set to transform the landscape of Parkinson’s disease therapy, researchers have unveiled compelling evidence that the angiotensin receptor blocker (ARB) candesartan exerts profound neuroprotective effects in affected patients. Leveraging advanced proteomic analysis of extracellular vesicles (EVs) derived from brain tissue, the study elucidates the intricate molecular mechanisms underpinning this protective action, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">304975</post-id>	</item>
		<item>
		<title>Centella asiatica Extract Enhances Brain Health in Mice</title>
		<link>https://bioengineer.org/centella-asiatica-extract-enhances-brain-health-in-mice/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 02 Dec 2025 01:39:55 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Centella asiatica]]></category>
		<category><![CDATA[cognitive function]]></category>
		<category><![CDATA[murine model]]></category>
		<category><![CDATA[Neuroprotection]]></category>
		<category><![CDATA[β-thalassemia]]></category>
		<guid isPermaLink="false">https://bioengineer.org/centella-asiatica-extract-enhances-brain-health-in-mice/</guid>

					<description><![CDATA[In recent years, scientific investigations into the medicinal properties of various natural extracts have gained momentum, particularly in addressing complex health issues like β-thalassemia and related iron overload syndromes. A groundbreaking study has emerged, shedding light on the potential benefits of a standardized extract of Centella asiatica, known as ECa 233. This research presents a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">304231</post-id>	</item>
		<item>
		<title>Probiotics Boost Cognitive Function: A Meta-Analysis Review</title>
		<link>https://bioengineer.org/probiotics-boost-cognitive-function-a-meta-analysis-review/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Tue, 25 Nov 2025 13:13:03 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[**Uygun Etiketler:** Probiotics]]></category>
		<category><![CDATA[cognitive function]]></category>
		<category><![CDATA[Gut-brain axis]]></category>
		<category><![CDATA[Meta-analysis]]></category>
		<category><![CDATA[Neuroprotection]]></category>
		<category><![CDATA[Neuroprotection **Virgülle Ayrılmış Hali:** Probiotics]]></category>
		<guid isPermaLink="false">https://bioengineer.org/probiotics-boost-cognitive-function-a-meta-analysis-review/</guid>

					<description><![CDATA[In recent years, the intersection of nutrition and cognitive health has garnered significant interest, particularly in the arena of probiotics. A groundbreaking systematic review and meta-analysis published in BMC Complementary Medicine and Therapies has scrutinized the efficacy and safety of probiotic supplements in enhancing cognitive function. The study by Calzada-Gonzales et al. probes into existing [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">301055</post-id>	</item>
		<item>
		<title>Estrogen Receptor Protects Hippocampal Neurons from Amyloid β</title>
		<link>https://bioengineer.org/estrogen-receptor-protects-hippocampal-neurons-from-amyloid-%ce%b2/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 06 Nov 2025 22:50:58 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[Alzheimer's disease]]></category>
		<category><![CDATA[amyloid β]]></category>
		<category><![CDATA[electrophysiology]]></category>
		<category><![CDATA[Estrogen receptor α]]></category>
		<category><![CDATA[female mouse models.]]></category>
		<category><![CDATA[GIRK channels]]></category>
		<category><![CDATA[hippocampal neurons]]></category>
		<category><![CDATA[neurodegenerative diseases]]></category>
		<category><![CDATA[Neuroprotection]]></category>
		<category><![CDATA[sex differences]]></category>
		<guid isPermaLink="false">https://bioengineer.org/estrogen-receptor-protects-hippocampal-neurons-from-amyloid-%ce%b2/</guid>

					<description><![CDATA[In a groundbreaking study led by Luo et al., the intricacies of estrogen signaling within the context of neurodegenerative conditions have been explored, specifically focusing on the role of membrane-associated estrogen receptor α (mERα) in hippocampal neurons. The research reveals a novel aspect of estrogen’s neuroprotective effects, particularly in relation to amyloid β-induced dysregulation of [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">292930</post-id>	</item>
		<item>
		<title>Green Tea Polyphenols Protect Brain Barrier in Ischemia</title>
		<link>https://bioengineer.org/green-tea-polyphenols-protect-brain-barrier-in-ischemia/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 17 Oct 2025 03:18:26 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Blood-brain barrier]]></category>
		<category><![CDATA[Cerebral ischemia]]></category>
		<category><![CDATA[Green tea polyphenols]]></category>
		<category><![CDATA[Neuroprotection]]></category>
		<category><![CDATA[Retracted studies]]></category>
		<guid isPermaLink="false">https://bioengineer.org/green-tea-polyphenols-protect-brain-barrier-in-ischemia/</guid>

					<description><![CDATA[In a surprising twist in the field of medical research, a recent study has been retracted that aimed to explore the neuroprotective properties of green tea polyphenols, particularly in the context of cerebral ischemia. The initial premise of the research was centered on the assumption that specific compounds found in green tea could mitigate early [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">282613</post-id>	</item>
	</channel>
</rss>
